Michael Krainer

Wolfgang Lamm3
Camilla Natter2
Marion Gerschpacher2
Stephan Polterauer2
3Wolfgang Lamm
2Camilla Natter
2Marion Gerschpacher
2Stephan Polterauer
Learn More
  • Peter Horak, Erwin Tomasich, Petr Vaňhara, Kateřina Kratochvílová, Mariam Anees, Maximilian Marhold +6 others
  • 2014
Prostate cancer is the most prevalent cancer in males in developed countries. Tumor suppressor candidate 3 (TUSC3) has been identified as a putative tumor suppressor gene in prostate cancer, though its function has not been characterized. TUSC3 shares homologies with the yeast oligosaccharyltransferase (OST) complex subunit Ost3p, suggesting a role in(More)
BACKGROUND Autoantigens have been reported in a variety of tumors, providing insight into the interplay between malignancies and the immune response, and also giving rise to novel diagnostic and therapeutic concepts. Why certain tumor-associated proteins induce an immune response remains largely elusive. RESULTS This paper analyzes the proposed link(More)
  • Richard Schwameis, Christoph Grimm, Edgar Petru, Camilla Natter, Christine Staudigl, Wolfgang Lamm +6 others
  • 2015
OBJECTIVE C-reactive protein (CRP) has previously been shown to serve as a prognostic parameter in women with gynecologic malignancies. Due to the lack of valid prognostic markers for uterine leiomyosarcoma (ULMS) this study set out to investigate the value of pre-treatment CRP serum levels as prognostic parameter. METHODS Data of women with ULMS were(More)
Leiomyosarcomas represent the largest subtype of soft tissue sarcomas. Two subgroups can be distinguished, non-uterine (NULMS) and uterine leiomyosarcomas (ULMS). The aim of this retrospective study was to evaluate differences in clinical features and outcome between these two subgroups. Outcome and clinical-pathological parameters between 50 patients with(More)
  • Thorsten Fuereder, Volker Wacheck, Sabine Strommer, Peter Horak, Marion Gerschpacher, Wolfgang Lamm +2 others
  • 2014
BACKGROUND Endothelial progenitor cells (CEPs) and circulating endothelial cells (CECs) are potential biomarkers of response to anti-angiogenic treatment regimens. In the current study, we investigated the effect of docetaxel and sunitinib on CEP/CEC kinetics and clinical response in castration resistant prostate cancer (CRPC) patients. PATIENTS AND(More)
Purpose. Tc-99m tetrofosmin launched for myocardial studies has recently also shown a good detectability for several tumors. Data on PNET imaging by Tc-99m tetrofosmin are not yet available.Patient and method. In the case of a 21-year-old man suffering from pelvis PNET, Tc-99m tetrofosmin scintigraphy was performed additionally to CT and MRI.Results. The(More)
  • 1